Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta

Journal of Virology

Volumn 80, Issue 15, 2006, Pages 7748-7755

  Chang, Yao ^a,b   Lee, Heng Huan ^a   Chen, Yu Te ^a   Lu, Jean ^a   Wu, Shih Yi ^b   Chen, Chaio Wei ^b   Takada, Kenzo ^c   Tsai, Ching Hwa ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; IMMEDIATE EARLY PROTEIN BZLF1; PROTEIN RTA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REACTIVATION;

BASE SEQUENCE; CELL LINE; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; EPSTEIN-BARR VIRUS INFECTIONS; ETS-DOMAIN PROTEIN ELK-1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; KIDNEY; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 33746215094     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02608-05     Document Type: Article

References (56)

1. Adamson, A. L., D. Darr, E. Holley-Guthrie, R. A. Johnson, A. Mauser, J. Swenson, and S. Kenney. 2000. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J. Virol. 74:1224-1233.
2. Andrade, A. A., P. N. Silva, A. C. Pereira, L. P. De Sousa, P. C. Ferreira, R. T. Gazzinelli, E. G. Kroon, C. Ropert, and C. A. Bonjardim. 2004. The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication. Biochem. J. 381:437-446.
3. Baron, V., G. De Gregorio, A. Krones-Herzig, T. Virolle, A. Calogero, R. Ureis, and D. Mercola. 2003. Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo. Oncogene 22:4194-4204.
4. Biesiada, E., M. Razandi, and E. R. Levin. 1996. Egr-1 activates basic fibroblast growth factor transcription. Mechanistic implications for astrocyte proliferation. J. Biol. Chem. 271:18576-18581.
5. Calogero, A., L. Cuomo, M. D'Onofrio, U. de Grazia, P. Spinsanti, D. Mercola, A. Faggioni, L. Frati, E. D. Adamson, and G. Ragona. 1996. Expression of Egr-1 correlates with the transformed phenotype and the type of viral latency in EBV genome positive lymphoid cell lines. Oncogene 13:2105-2112.
6. Cao, X. M., G. R. Guy, V. P. Sukhatme, and Y. H. Tan. 1992. Regulation of the Egr-1 gene by tumor necrosis factor and interferons in primary human fibroblasts. J. Biol. Chem. 267:1345-1349.
7. 1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 15:2748-2759.
8. Cayrol, C., and E. K. Flemington. 1995. Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor βigh3 (TGF-βigh3) and TGF-β1. J. Virol. 69:4206-4212.
9. Chang, L. K., J. Y. Chung, Y. R. Hong, T. Ichimura, M. Nakao, and S. T. Liu. 2005. Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1. Nucleic Acids Res. 33:6528-6539.
10. Chang, Y., S. S. Chang, H. H. Lee, S. L. Doong, K. Takada, and C. H. Tsai. 2004. Inhibition of the Epstein-Barr virus lytic cycle by Zta-targeted RNA interference. J. Gen. Virol. 85:1371-1379.
11. Chang, Y., H. H. Lee, S. S. Chang, T. Y. Hsu, P. W. Wang, Y. S. Chang, K. Takada, and C. H. Tsai. 2004. Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta. J. Virol. 78:13028-13036.
12. Chang, Y., C. H. Tung, Y. T. Huang, J. Lu, J. Y. Chen, and C. H. Tsai. 1999. Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes. J. Virol. 73:8857-8866.
13. Chang, Y. N., D. L. Dong, G. S. Hayward, and S. D. Hayward. 1990. The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. J. Virol. 64:3358-3369.
14. Chapman, N. R., and N. D. Perkins. 2000. Inhibition of the RelA(p65) NF-κB subunit by Egr-1. J. Biol. Chem. 275:4719-4725.
15. Chauhan, D., S. M. Kharbanda, H. Uchiyama, V. P. Sukhatme, D. W. Kufe, and K. C. Anderson. 1994. Involvement of serum response element in okadaic acid-induced EGR-1 transcription in human T-cells. Cancer Res. 54:2234-2239.
16. Daibata, M., S. H. Speck, C. Mulder, and T. Sairenji. 1994. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells. Virology 198:446-454.
17. Fahmi, H., C. Cochet, Z. Hmama, P. Opolon, and I. Joab. 2000. Transforming growth factor β1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway. J. Virol. 74:5810-5818.
18. Feederle, R., M. Kost, M. Baumann, A. Janz, E. Drouet, W. Hammerschmidt, and H. J. Delecluse. 2000. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 19:3080-3089.
19. Feng, W. H., G. Hong, H. J. Delecluse, and S. C. Kenney. 2004. Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas. J. Virol. 78:1893-1902.
20. Flemington, E., and S. H. Speck. 1990. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64:1227-1232.
21. Flemington, E., and S. H. Speck. 1990. Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c-fos. J. Virol. 64:4549-4552.
22. Flemington, E. K., A. E. Goldfeld, and S. H. Speck. 1991. Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis. J. Virol. 65:7073-7077.
23. Fujii, M., H. Tsuchiya, T. Chuhjo, T. Minamino, K. Miyamoto, and M. Seiki. 1994. Serum response factor has functional roles both in indirect binding to the CArG box and in the transcriptional activation function of human T-cell leukemia virus type 1 Tax. J. Virol. 68:7275-7283.
24. Gao, X., K. Ikuta, M. Tajima, and T. Sairenji. 2001. 12-O-Tetradecanoyl- phorbol-13-acetate induces Epstein-Barr virus reactivation via NF-κB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase. Virology 286:91-99.
25. Gille, H., M. Kortenjann, O. Thomae, C. Moomaw, C. Slaughter, M. H. Cobb, and P. E. Shaw. 1995. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J. 14:951-962.
26. Hodge, C., J. Liao, M. Stofega, K. Guan, C. Carter-Su, and J. Schwartz. 1998. Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, cgr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J. Biol. Chem. 273:31327-31336.
27. Kenney, S., J. Kamine, E. Holley-Guthrie, J. C. Lin, E. C. Mar, and J. Pagano. 1989. The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters. J. Virol. 63:1729-1736.
28. Kharbanda, S., T. Nakamura, R. Stone, R. Hass, S. Bernstein, R. Datta, V. P. Sukhatme, and D. Kufe. 1991. Expression of the early growth response 1 and 2 zinc finger genes during induction of monocytic differentiation. J. Clin. Investig. 88:571-577.
29. Kouzarides, T., G. Packham, A. Cook, and P. J. Farrell. 1991. The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper. Oncogene 6:195-204.
30. Krones-Herzig, A., S. Mittal, K. Yule, H. Liang, C. English, R. Urcis, T. Soni, E. D. Adamson, and D. Mercola. 2005. Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. Cancer Res. 65:5133-5143.
31. Lim, C. P., N. Jain, and X. Cao. 1998. Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1. Oncogene 16:2915-2926.
32. Lin, C. T., W. Y. Chan, W. Chen, H. M. Huang, H. C. Wu, M. M. Hsu, S. M. Chuang, and C. C. Wang. 1993. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab. Investig. 68:716-727.
33. Liu, C., E. Adamson, and D. Mercola. 1996. Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor β1. Proc. Natl. Acad. Sci. USA 93:11831-11836.
34. Lu, J., S. Y. Chen, H. H. Chua, Y. S. Liu, Y. T. Huang, Y. Chang, J. Y. Chen, T. S. Sheen, and C. H. Tsai. 2000. Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta. J. Virol. 74:7391-7399.
35. Mahot, S., A. Sergeant, E. Drouet, and H. Gruffat. 2003. A novel function for the Epstein-Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene. J. Gen. Virol. 84:965-974.
36. Mauser, A., S. Saito, E. Appella, C. W. Anderson, W. T. Seaman, and S. Kenney. 2002. The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J. Virol. 76:12503-12512.
37. McMahon, S. B., and J. G. Monroe. 1995. A ternary complex factor-dependent mechanism mediates induction of egr-1 through selective serum response elements following antigen receptor cross-linking in B lymphocytes. Mol. Cell. Biol. 15:1086-1093.
38. Morrison, T. E., and S. C. Kenney. 2004. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function. Virology 328:219-232.
39. Nair, P., S. Muthukkumar, S. F. Sells, S. S. Han, V. P. Sukhatme, and V. M. Rangnekar. 1997. Early growth response-1-dependent apoptosis is mediated by p53. J. Biol. Chem. 272:20131-20138.
40. Nilsson, T., H. Zetterberg, Y. C. Wang, and L. Rymo. 2001. Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines. J. Virol. 75:5796-5811.
41. Perez-Castillo, A., C. Pipaon, I. Garcia, and S. Alemany. 1993. NGF1-A gene expression is necessary for T lymphocyte proliferation. J. Biol. Chem. 268:19445-19450.
42. Ragoczy, T., and G. Miller. 1999. Role of the Epstein-Barr virus RTA protein in activation of distinct classes of viral lytic cycle genes. J. Virol. 73:9858-9866.
43. Rickinson, A. B., and E. Kieff. 2001. Epstein-Barr virus, p. 2575-2627. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
44. Santiago, F. S., H. C. Lowe, F. L. Day, C. N. Chesterman, and L. M. Khachigian. 1999. Early growth response factor-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor-2. Am. J. Pathol. 154:937-944.
45. Schwachtgen, J. L., C. J. Campbell, and M. Braddock. 2000. Full promoter sequence of human early growth response factor-1 (Egr-1): demonstration of a fifth functional serum response element. DNA Seq. 10:429-432.
46. Schwachtgen, J. L., P. Houston, C. Campbell, V. Sukhatme, and M. Braddock. 1998. Fluid shear stress activation of egr-1 transcription in cultured human endothelial and epithelial cells is mediated via the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway. J. Clin. Investig. 101:2540-2549.
47. Shozu, M., K. Murakami, T. Segawa, T. Kasai, H. Ishikawa, K. Shinohara, M. Okada, and M. Inoue. 2004. Decreased expression of early growth response-1 and its role in uterine leiomyoma growth. Cancer Res. 64:4677-4684.
48. Sinclair, A. J., M. Brimmell, F. Shanahan, and P. J. Farrell. 1991. Pathways of activation of the Epstein-Barr virus productive cycle. J. Virol. 65:2237-2244.
49. Sukhatme, V. P., X. M. Cao, L. C. Chang, C. H. Tsai-Morris, D. Stamenkovich, P. C. Ferreira, D. R. Cohen, S. A. Edwards, T. B. Shows, T. Curran, et al. 1988. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53:37-43.
50. Suva, L. J., M. Ernst, and G. A. Rodan. 1991. Retinoic acid increases zif268 early gene expression in rat preosteoblastic cells. Mol. Cell. Biol. 11:2503-2510.
51. Thyss, R., V. Virolle, V. Imbert, J. F. Peyron, D. Aberdam, and T. Virolle. 2005. NF-κB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death. EMBO J. 24:128-137.
52. Treisman, R. 1995. Journey to the surface of the cell: Fos regulation and the SRE. EMBO J. 14:4905-4913.
53. +-T-cell lines. J. Virol. 77:1392-1402.
54. Virolle, T., E. D. Adamson, V. Baron, D. Birle, D. Mercola, T. Mustelin, and I. de'Belle. 2001. The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat. Cell Biol. 3:1124-1128.
55. Wright, J. J., K. C. Gunter, H. Mitsuya, S. G. Irving, K. Kelly, and U. Siebenlist. 1990. Expression of a zinc finger gene in HTLV-I- and HTLV-II-transformed cells. Science 248:588-591.
56. Zalani, S., E. Holley-Guthrie, and S. Kenney. 1995. The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter. J. Virol. 69:3816-3823.